The Anti-Pseudomonas aeruginosa Antibody Panobacumab Is Efficacious on Acute Pneumonia in Neutropenic Mice and Has Additive Effects with Meropenem

Quantitative Impact of Neutrophils on Bacterial Clearance in a Murine Pneumonia Model

(2011) Beining Guo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

PcrV antibody–antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice

(2011) Y. Song et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection

(2011) T. Secher et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia

(2011) Q. Lu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Innate immune responses to Pseudomonas aeruginosa infection

(2011) Elise G. Lavoie et al.   MICROBES AND INFECTION

Morbidity and Mortality of Bloodstream Infections in Patients With Severe Burn Injury

(2010) N. Brusselaers et al.   AMERICAN JOURNAL OF CRITICAL CARE

Preclinical In Vitro and In Vivo Characterization of the Fully Human Monoclonal IgM Antibody KBPA101 Specific for Pseudomonas aeruginosa Serotype IATS-O11

(2010) M. P. Horn et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics and Safety Profile of the Human Anti-Pseudomonas aeruginosa Serotype O11 Immunoglobulin M Monoclonal Antibody KBPA-101 in Healthy Volunteers

(2009) H. Lazar et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Inescapable Need for Neutrophils as Mediators of Cellular Innate Immunity to Acute Pseudomonas aeruginosa Pneumonia

(2009) A. Y. Koh et al.   INFECTION AND IMMUNITY

Protective effects of affinity-purified antibody and truncated vaccines againstPseudomonas aeruginosaV-antigen in neutropenic mice

(2009) Kiyoshi Moriyama et al.   MICROBIOLOGY AND IMMUNOLOGY

Pseudomonas aeruginosa LPS or Flagellin Are Sufficient to Activate TLR-Dependent Signaling in Murine Alveolar Macrophages and Airway Epithelial Cells

(2009) Eloïse Raoust et al.   PLoS One

An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity

(2008) M. Baer et al.   INFECTION AND IMMUNITY